Panacos Pharmaceuticals, Inc. (PANC)
- Previous Close
0.0000 - Open
0.0000 - Bid --
- Ask --
- Day's Range
0.0000 - 0.0000 - 52 Week Range
0.0000 - 0.0085 - Volume
200 - Avg. Volume
28,907 - Market Cap (intraday)
53 - Beta (5Y Monthly) -100.18
- PE Ratio (TTM)
-- - EPS (TTM)
-0.6670 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
3.00
Panacos Pharmaceuticals, Inc., a development stage biotechnology company, engages in the discovery and development of small-molecule oral drugs designed to treat human immunodeficiency virus (HIV) and other human viral diseases. The company's discovery technologies focus on novel targets in the virus life cycle, including virus maturation and virus fusion. Its product pipeline includes second- and third-generation programs in HIV maturation inhibition. The company was founded in 1999 and is headquartered in Watertown, Massachusetts.
41
Full Time Employees
December 31
Fiscal Year Ends
--
Sector
--
Industry
Related News
Performance Overview: PANC
Trailing total returns as of 4/27/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PANC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PANC
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-52.62%
Return on Equity (ttm)
-168.83%
Revenue (ttm)
99k
Net Income Avi to Common (ttm)
-35.76M
Diluted EPS (ttm)
-0.6670
Balance Sheet and Cash Flow
Total Cash (mrq)
26.89M
Total Debt/Equity (mrq)
345.33%
Levered Free Cash Flow (ttm)
-16.93M
Research Analysis: PANC
Company Insights: PANC
PANC does not have Company Insights